Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM3VQ1Y)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Proteasome beta-8 (PS beta-8)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
M3258	DM6PI5B	Multiple myeloma	2A83	Phase 1	[2]
Peptide analog 21	DMJDFS1	N. A.	N. A.	Patented	[1]
Peptide analog 23	DMDU21R	N. A.	N. A.	Patented	[1]
Peptide analog 41	DM96KXE	N. A.	N. A.	Patented	[1]
PMID29865878-Compound-53	DM6JV1W	N. A.	N. A.	Patented	[1]
PMID29865878-Compound-55	DMY52ZB	N. A.	N. A.	Patented	[1]
PMID29865878-Compound-46	DMP3MXK	N. A.	N. A.	Patented	[1]
PMID29865878-Compound-48	DMVQTR2	N. A.	N. A.	Patented	[1]
PMID29865878-Compound-51	DM0LXT2	N. A.	N. A.	Patented	[1]
PMID29865878-Compound-49	DMK0GTV	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	A patent review of immunoproteasome inhibitors.Expert Opin Ther Pat. 2018 Jul;28(7):517-540.
2	Clinical pipeline report, company report or official report of EMD Serono.